Nuclear Medicine and Molecular Imaging
Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) publishes papers on nuclear medicine and a wide range of related sciences including radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal also presents original works relating to molecular imaging research, such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Content includes original articles, reviews, case reports, editorials, interesting images, and letters to the editor. Nucl Med Mol Imaging is an official journal of the Korean Society of Nuclear Medicine. KSNM members read this journal plus the official journals of the EANM and the Japanese Nuclear Medicine Society online for free.
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirementsAll contributions should also follow the good publication practice guidelines for medical journals, which were established by Korean Association of Medical Journal Editors
- 5 Volumes
- 20 Issues
- 312 Articles
- 2 Open Access
- 2010 - 2014 Available between
Assessment of Therapy Response by 18F-FDG PET/CT for a Patient with Cutaneous and Subcutaneous Mycobacterium Infection and Coexisting Lymphoma
Yang Lu (December 2014)
To view the rest of this content please follow the download PDF link above.